Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Insulin analogues: searching for a physiological replacement].

Francisca Eyzaguirre1, Ethel Codner

  • 1Hospital Clínico San Borja Arriarán, Campus Centro, Universidad de Chile, Chile.

Revista Medica De Chile
|March 24, 2006
PubMed
Summary

Insulin analogues, engineered for improved action profiles, offer better diabetes management. Studies show they enhance metabolic control and reduce hypoglycemia compared to human insulin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delays in Access to Innovative Diabetes Therapies: A Persistent Inequity in Latin America.

Diabetes care·2025
Same author

Clinical and Demographic Characteristics Associated with Type 1 Diabetes Distress in Latin American Children.

Journal of pediatrics. Clinical practice·2025
Same author

Anti-Müllerian hormone, sex steroids, and metabolic profile in cord blood of pregnancies with type 2 diabetes and gestational diabetes.

Frontiers in endocrinology·2025
Same author

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes.

Hormone research in paediatrics·2025
Same author

Differential Effect of 2 Hormonal Contraceptives on the Relative Telomere Length of Youth With Type 1 Diabetes.

Journal of the Endocrine Society·2024
Same author

Subdermal Progestin Implant and an Oral Combined Hormonal Contraceptive in Youth with Type 1 Diabetes.

Journal of pediatric and adolescent gynecology·2023

Area of Science:

  • Endocrinology and Metabolism
  • Pharmacology
  • Biotechnology

Background:

  • Insulin therapy is crucial for managing diabetes mellitus.
  • Traditional human insulins (NPH, regular) have limitations in mimicking physiological insulin secretion.
  • Molecular engineering has led to the development of insulin analogues with modified action profiles.

Purpose of the Study:

  • To review the development and therapeutic applications of insulin analogues.
  • To compare the efficacy and safety of insulin analogues versus human insulins.
  • To highlight the benefits of insulin analogues in diabetes management.

Main Methods:

  • Review of studies comparing insulin analogues (rapid-acting and long-acting) with human insulins.
  • Analysis of data on metabolic control, glycemic variability, and adverse events (e.g., hypoglycemia).
  • Evaluation of impact on quality of life in patients with type 1 and type 2 diabetes mellitus.

Main Results:

  • Rapid-acting analogues (lispro, aspart, glulisine) demonstrate faster absorption and improved postprandial glucose control.
  • Long-acting analogues (glargine, detemir) provide sustained basal insulin levels.
  • Comparative studies show insulin analogues lead to better metabolic control and fewer hypoglycemic events than human insulins.

Conclusions:

  • Insulin analogues represent a significant advancement in insulin replacement therapy.
  • Basal-bolus therapy combining long-acting and rapid-acting analogues optimizes glycemic control.
  • Insulin analogues offer improved therapeutic options for individualized intensive diabetes treatment, enhancing patient outcomes and quality of life.

Related Experiment Videos